Literature DB >> 9618001

Mouse running activity is lowered by Brucella abortus treatment: a potential model to study chronic fatigue.

J E Ottenweller1, B H Natelson, W C Gause, K K Carroll, D Beldowicz, X D Zhou, J J LaManca.   

Abstract

Chronic fatigue syndrome, which can occur after acute infection and last for years, is characterized by severe and persistent fatigue. Others have reported decreases in mouse running activity following infection and have suggested this may provide an animal model for studying chronic fatigue. Voluntary running is a highly motivated activity in mice, which will often run 5-7 mi/day in our laboratory. Following 2 weeks of acclimation to running wheels with food and water available ad lib, female BALB/c mice received 0.2-mL tail vein injections of killed Brucella abortus (BA) or saline vehicle. Subsequently the effects on voluntary running and grooming behavior were determined. Injection of BA caused an immediate large decrease in running and a lack of grooming. Vehicle injections produced no changes in behavior. After the first several days of reduced running behavior, levels of running and grooming slowly returned back to normal over the next 2-4 weeks, with substantial individual differences in the rate of recovery. The pattern of running during recovery was intriguing in that BA mice first ran at normal levels just after the lights went out, but they stopped after only 1-2 h. As recovery proceeded, they gradually increased the duration of the running bout during the night. Because this model uses voluntary exertion and the ability to run for longer periods of time characterizes recovery, the model may be a good one for studying the biologic underpinnings of chronic fatigue.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9618001     DOI: 10.1016/s0031-9384(97)00539-8

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  11 in total

1.  Effects of exercise on behavior and peripheral blood lymphocyte apoptosis in a rat model of chronic fatigue syndrome.

Authors:  Jun Zou; Jianqi Yuan; Shuang Lv; Jiaheng Tu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-04-21

Review 2.  Chronic fatigue syndrome: an update.

Authors:  R J Shephard
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 3.  Neurobiological studies of fatigue.

Authors:  Mary E Harrington
Journal:  Prog Neurobiol       Date:  2012-07-24       Impact factor: 11.685

Review 4.  Fatigue and sleep during cancer and chemotherapy: translational rodent models.

Authors:  Maria Ray; Laura Q Rogers; Rita A Trammell; Linda A Toth
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

5.  Brain atrophy in a murine model of chronic fatigue syndrome and beneficial effect of Hochu-ekki-to (TJ-41).

Authors:  Rui Chen; Junji Moriya; Jun-ichi Yamakawa; Takashi Takahashi; Qian Li; Shigeto Morimoto; Kunimitsu Iwai; Hiroyuki Sumino; Nobuo Yamaguchi; Tsugiyasu Kanda
Journal:  Neurochem Res       Date:  2008-03-04       Impact factor: 3.996

6.  Effects of 5-fluorouracil chemotherapy on fatigue: role of MCP-1.

Authors:  S E Mahoney; J M Davis; E A Murphy; J L McClellan; B Gordon; M M Pena
Journal:  Brain Behav Immun       Date:  2012-10-17       Impact factor: 7.217

7.  Induction Murine Models of Chronic Fatigue Syndrome by Brucella abortus Antigen Injections: Is Anemia Induced or Not?

Authors:  Junji Moriya; Qiang He; Hiroaki Uenishi; Sumiyo Akazawa; Jun-Ichi Yamakawa; Junji Kobayashi; Yasuhito Ishigaki
Journal:  Biomed Res Int       Date:  2015-06-11       Impact factor: 3.411

8.  Isoflavones inhibit poly(I:C)-induced serum, brain, and skin inflammatory mediators - relevance to chronic fatigue syndrome.

Authors:  Magdalini Vasiadi; Jennifer Newman; Theoharis C Theoharides
Journal:  J Neuroinflammation       Date:  2014-10-31       Impact factor: 8.322

9.  Beneficial effect of brewers' yeast extract on daily activity in a murine model of chronic fatigue syndrome.

Authors:  Takashi Takahashi; Fei Yu; Shi-Jie Zhu; Junji Moriya; Hiroyuki Sumino; Shigeto Morimoto; Nobuo Yamaguchi; Tsugiyasu Kanda
Journal:  Evid Based Complement Alternat Med       Date:  2006-01-23       Impact factor: 2.629

10.  Effect of Hochu-ekki-to (TJ-41), a Japanese Herbal Medicine, on Daily Activity in a Murine Model of Chronic Fatigue Syndrome.

Authors:  Xin Q Wang; Takashi Takahashi; Shi-Jie Zhu; Junji Moriya; Seiichiro Saegusa; Jun'ichi Yamakawa; Kazuya Kusaka; Tohru Itoh; Tsugiyasu Kanda
Journal:  Evid Based Complement Alternat Med       Date:  2004-09-01       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.